Emrah SAPMAZ, İsmail İYNEN, Bakar Selma DERTLİOĞLU, Demet ÇİÇEK POSTA

TÜRKİYE’DE BULUNAN VİTİLOGOLU HASTALARIN İŞİTMELERİNİN DEĞERLENDİRİLMESİ

Amaç:Vitiligo, depigmente makula ve belirgin melanosit yıkımıyla karekterize edinsel, idiopatik, otoimmün bir hastalıktır. Çalışma vitilogo hastalarında olası odyolojik anormallikleri saptamak için planlandı. Konvansiyonel odyolojik testlerle (saf ses eşiği ) ve transient otoakustik emisyon (TEOAE) ile vitiligo hastalarında koklear fonksiyonları ölçtük ve kontrol grubuyla karşılaştırdık. Materyal ve Metot: Vitiligolu 32 hasta cinsiyetçe benzer 32 sağlıklı kişi çalışmaya alındı. Odyometrik ve TEOAE testleri hasta ve kontrol grubunda yapıldı. Odyometrik ölçümler ses geçirmeyen kabinde saf ses odyometriyle yapıldı. Saf ses eşikleri 250-6000 Hz'de her kulak için ölçüldü.Bulgular: Odyometrik bulgular vitiligolu hastalar ve kontrol grubu arasında 250-6000 Hz arası saf ses eşiklerinde fark olmadığını ortaya koydu. Vitiligolu hastalarda saf ses odyogramda sensörinöral işitme kaybı yoktu. Vitiligolu hastalarda saf ses odyometride değişiklik olmasa da transient otoakustik emisyon değerlerindeki düşmelerin dış tüy hücrelerini etkilediği düşünülebilir.Sonuç:Konvansiyonel odyometri ile birlikte TEOAE testleri koklear disfonsiyonun erken tanısında güvenilir testlerdir. Vitiligolu hastalarda hastalığın ilerlemesi ve erken fark edilmesi açısından odyolojik incelemenin rutin olarak yapılması gerektiğini düşünüyoruz

An Evaluation of the Hearing Examinations of Vitiligo Patients in Turkey

Objective:Vitiligo is an acquired, idiopathic autoimmune disease characterized by depigmented maculae and marked with melanocyte destruction. The study was performed to detect possible audiological abnormalities in vitiligo patients. We aimed to use conventional audiological tests (pure tone threshold) and altered cochlear function, by measuring and analyzing transient evoked otoacoustic emission (TEOAE) testing any subclinical auditory abnormalities of in patients with vitiligo, compared with controls.Materials and Methods: Thirty-three patients with vitiligo and 32 age- and sex-matched healthy control cases were included in this study. Audiometric and TEOAE testings for both ears were performed for both patients and controls. Audiometric examinations were performed using a pure tone audiometer in a silent cabin. Pure tone thresholds were determined for each ear at frequencies of 250 – 6000 Hz for air conduction. Results:Findings of the audiometric tests indicate that there was no difference between vitiligo and control group cases in pure tone threshold values between 250 and 6000 Hz. There was not sensorineural hearing loss on pure-tone audiogram in patients with vitiligo. Although there is no change in pure tone audiometry in vitiligo patients, it is considered that reductions in transient evoked otoacoustic emission values began to affect the outer hairy cells.Conclusion:Conventional audiometry with TEOAE testing are reliable tests for the early detection of cochlear dysfunction. All patients with vitiligo required routine monitoring and audiological assessments for early identification and monitoring of changes as the disease progresses

PDF

___

1. Aydogan K, Turan OF, Onart S, Karadogan SK, Tunali S. Audiological abnormalities inpatients with vitiligo. Clin Exp Dermatol. 2006;31(1):110-13.
2. Hong CK, Lee MH, Jeong KH, Cha CI, Yeo SG. Clinical analysis of hearing levels in vitiligo patients. Eur J Dermatol 2009;19(1):50-6.
3. Ardiç FN, Aktan S, Kara CO, Sanli B.High-frequency hearing and reflex latency in patients with pigment disorder. Am J Otolaryngol. 1998;19(6):365-69.
4. Tosti A, Bardazzi F, Tosti G, Monti L. Audiologic abnormalities in casesof vitiligo. J Am Acad Dermatol. 1987;17(2):230-33.
5. Nawaf Al-Mutairi, Khalid H, Al-Sebeih. Late onset vitiligo and audiological abnormalities: Is there any association? Indian J Dermatol Venereol Leprol. 2011;77(5):571-76 .
6. Escalante-Ugalde C, Poblano A, Montes de Oca E, Lagunes R, Saúl A. No evidence of hearing loss in patients with vitiligo. Arch Dermatol. 1991;127(8):1240.
7. Livingston EH, Lee S. Percentage of burned body surface area determination in obese and nonobese patients. J Surg Res. 2000;91(2):106-10.
8. Aslan S, Serarslan G, Teksoz E, Dagli S. Audiological and transient evoked otoacoustic emission findings in patients with vitiligo. Otolaryngology–Head and Neck Surgery. 2010;142(3):409-14.
9. Angrisani RM1, Azevedo MF, Pereira LD, Lopes C, Garcia MV. A study on otoacoustic emissions and supression effects in patients with vitiligo. Braz J Otorhinolaryngol. 2009;75(1):111-15.
10. Steel KP, Barkway C. Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development. 1989;107(3):453-63.
11. Savin MSC. The blood vessels and Pigmentary Cells of the Inner Ear. Ann Otol Rhinol Laryngol. 1965;74(3):611-23.
12. Kemp DT. Otoacoustic emissions, their origin in cochlear function,and use. Br Med Bull. 2002;63:223-41.
13. Fleissig E, Gross M, Ophir I, Elidan J, Bdolah-Abram T, Ingber A. Risk of sensorineural hearing loss in patients with vitiligo. Audiol Neurootol. 2013;18(4):240-46.
14. Gopal KV, Rama Rao GR, Kumar YH, Appa Rao MV, Vasudev P; Srikant. Vitiligo: a part of a systemic autoimmune process. Indian J Dermatol Venereol Leprol. 2007;73(3):162- 65.
15. Sharma L, Bhawan R, Jain RK. Hypoacusis in Vitiligo. Indian J Dermatol Venereol Leprol 2004;70(3):162-64.
16. Mahdi P, Rouzbahani M, Amali A, Rezaii Khiabanlu S, Kamali M. Audiological manifestations in vitiligo patients. Iran J Otorhinolaryngol. 2012;24(66):35-40.
17. Akay BN, Bozkir M, Anadolu Y, Gullu S. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venereol. 2010;24:1144-50.